RO7198457

· BioNTech SE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7198457, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer [Phase 2]

See pricing